Skip to content

Deferred Revenue at other companies

Absci Corporation logo
Absci CorporationABSI
$450K-58.9%
UFP Technologies logo
UFP TechnologiesUFPT
$4.63M-3.5%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$188.1M+16.0%
iRadimed logo
iRadimedIRMD
$3.4M+30.7%
Oceaneering International logo
Oceaneering InternationalOII
$114.83M+8.1%
ROP
Roper Technologies, Inc.ROP
$1.79B+7.5%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-24.8%
Enterprise value$1.25B
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's deferred revenue?
PROCEPT BioRobotics Corporation (PRCT) reported deferred revenue of $13.7M in Q1 2026.
How has PROCEPT BioRobotics Corporation's deferred revenue changed year-over-year?
PROCEPT BioRobotics Corporation's deferred revenue increased by 39.8% year-over-year, from $9.8M to $13.7M.
What is the long-term trend for PROCEPT BioRobotics Corporation's deferred revenue?
Over 5 years (2020 to 2025), PROCEPT BioRobotics Corporation's deferred revenue has grown at a 123.7% compound annual growth rate (CAGR), from $233K to $13.05M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.